Abnormal cell cycle regulation due to Cyclin D1 overexpression is a common occurrence in human cancers (including NPC), and both EGFR and STAT3 could target cyclin D1 promoter activity[31,35,46]. The gene discussed is STAT3; the disease is cancer.